To continue using this website, please tell us a
little about yourself:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here

Login

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
 
 
Poll

How much of your portfolio is in passive funds?

0%
0% to 25%
25% to 50%
50% or more
100%

Vote

 
You are here: Factsheet
 

Zurich Sterling AXA Framlington Health

3 FE Trustnet

Underlying Fund

FE Crown Rating ( Underlying )

Fund Objective ( Underlying )

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies.

Fund Manager ( Underlying )

Dani Saurymper

Domicile

Sector

Currency

Primary Asset Class

Fund Size

GBP 8.19m as at 31-Dec-2015

Downloads ( Underlying )

Unit Name

Zurich Sterling AXA Framlington Health S2

Inc/Acc

Accumulating 

Citicode

AFK3

Initial Charge

n/a

Unit Currency

GBX 

ISIN

GB00B1W4T101 

Annual Charge

0.85%

Mid

GBX 253.40

Change (Mid)

-0.50 (-0.20%)
10-Feb-2016

Unit LaunchDate

06-Aug-2007

Unit Name

Zurich Sterling AXA Framlington Health

Inc/Acc

Accumulating 

Citicode

SP03

Initial Charge

n/a

Unit Currency

GBX 

ISIN

GB0003251013 

Annual Charge

1.85%

Bid

GBX 42.00

Offer

GBX 44.30

Change (Offer)

0.00 (0.00%)
10-Feb-2016

Unit LaunchDate

04-Dec-2000

Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund -11.76 -8.30 -14.29 -6.46 40.47 84.21
Sector -5.33 -5.14 -6.31 -4.99 7.58 13.29

Discrete Performance (%)

  2015 2014 2013 2012 2011
Fund 9.43 24.64 30.22 10.74 4.76
Sector 2.04 5.16 10.14 6.76 -5.30

Asset Allocation ( Underlying )

breakdown chart
  Asset Class % of Fund
North American Equities 70.17
Europe ex UK Equities 13.77
UK Equities 10.66
Global Emerging Market Equities 1.77
Japanese Equities 1.67
Money Market 1.45
Asia Pacific ex Japan Equities 0.51

Regional Breakdown ( Underlying )

breakdown chart
  Region % of Fund
North America 70.17
Europe Ex UK 13.77
UK 10.66
Emerging 1.77
Japan 1.67
Cash 1.45
Developed Asia Pacific ex Japan 0.51

Sector Breakdown ( Underlying )

breakdown chart
  Sector % of Fund
Biotechnology, Life Sciences Tools & Services 30.44
Pharmaceuticals 29.89
Managed Health Care, Health Care Distributors, Health Care Services 17.89
Health Care Equipment 14.55
Other 3.96
Health Care Facilities 1.82
Cash 1.45
 

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.

Data provided by FE. Care has been taken to ensure that the information is correct, but FE neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.